High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.8M
$2,838,473
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-20 | $30,246 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-19 | $129,705 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-18 | $122,415 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-09 | $704,657 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-06 | $71,572 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-05 | $33,464 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-04 | $49,289 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 SellΔOwn -11.7%
|
2025-11-24 | $776,429 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2025-10-16 | $453,761 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2025-10-15 | $250,391 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2025-10-13 | $216,545 | S | Form 4 |